Sucampo Pharmaceuticals, Inc.
SCMP
SCMP was delisted on the 12th of February, 2018.
91 hedge funds and large institutions have $182M invested in Sucampo Pharmaceuticals, Inc. in 2014 Q4 according to their latest regulatory filings, with 32 funds opening new positions, 33 increasing their positions, 20 reducing their positions, and 8 closing their positions.
400% more call options, than puts
Call options by funds: $1.25M | Put options by funds: $250K
300% more first-time investments, than exits
New positions opened: 32 | Existing positions closed: 8
180% more capital invested
Capital invested by funds: $64.9M → $182M (+$117M)
65% more repeat investments, than reductions
Existing positions increased: 33 | Existing positions reduced: 20
32% more funds holding
Funds holding: 69 → 91 (+22)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
+$6.15M |
| 2 |
OAM
Oxford Asset Management
Oxford,
United Kingdom
|
+$3.13M |
| 3 |
BA
BlackRock Advisors
Wilmington,
Delaware
|
+$3.08M |
| 4 |
BIT
BlackRock Institutional Trust
San Francisco,
California
|
+$2.86M |
| 5 |
TC
TFS Capital
West Chester,
Pennsylvania
|
+$2.74M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VAM
Visium Asset Management
New York
|
-$11.4M |
| 2 |
PI
Putnam Investments
Boston,
Massachusetts
|
-$2.5M |
| 3 |
CCM
Cadence Capital Management
Boston,
Massachusetts
|
-$992K |
| 4 |
NFA
Nationwide Fund Advisors
Columbus,
Ohio
|
-$601K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
-$583K |
SCMP Hedge Fund Activity: Q4 2014 in Review
91 of the 3,750 institutional investors tracked by Wall St. Rank reported a position in Sucampo Pharmaceuticals, Inc. (SCMP) for Q4 2014, worth a combined $182M — up 180% from $64.9M a quarter earlier.
Buyers outnumbered sellers: 32 funds opened new SCMP positions and 8 closed out — a net gain of 24 holders — while 33 added to existing stakes and 20 trimmed.
The largest buyer was Millennium Management, adding an estimated $6.15M. The largest seller was Visium Asset Management, cutting an estimated $11.4M.
- 91 institutional investors held Sucampo Pharmaceuticals, Inc. (SCMP) as of Q4 2014, up from 69 in Q3 2014.
- Funds reported $182M of Sucampo Pharmaceuticals, Inc. stock for Q4 2014, up 180% quarter-over-quarter.
- 32 funds opened new Sucampo Pharmaceuticals, Inc. positions in Q4 2014 and 8 closed out, a net change of +24 holders.
- The largest Sucampo Pharmaceuticals, Inc. buyer in Q4 2014 was Millennium Management, an estimated $6.15M added.
- The largest Sucampo Pharmaceuticals, Inc. seller in Q4 2014 was Visium Asset Management, an estimated $11.4M sold.
Based on aggregated 13F filings for Q4 2014.